- Record: found
- Abstract: not found
- Article: not found
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial
Bo Xu ,
Shengxian Tu ,
Lei Song ,
Zening Jin ,
Bo Yu ,
Guosheng Fu ,
Yujie Zhou ,
Jian’an Wang ,
Yundai Chen ,
Jun Pu ,
Lianglong Chen ,
Xinkai Qu ,
Junqing Yang ,
Xuebo Liu ,
Lijun Guo ,
Chengxing Shen ,
Yaojun Zhang ,
Qi Zhang ,
Hongwei Pan ,
Xiaogang Fu ,
Jian Liu ,
Yanyan Zhao ,
Javier Escaned ,
Yang Wang ,
William F Fearon ,
Kefei Dou ,
Ajay J Kirtane ,
Yongjian Wu ,
Patrick W Serruys ,
Weixian Yang ,
William Wijns ,
Changdong Guan ,
Martin B Leon ,
Shubin Qiao ,
Gregg W Stone
November 2021
November 2021
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p class="first" id="d16073917e551">Compared with visual angiographic assessment,
pressure wire-based physiological measurement
more accurately identifies flow-limiting lesions in patients with coronary artery
disease. Nonetheless, angiography remains the most widely used method to guide percutaneous
coronary intervention (PCI). In FAVOR III China, we aimed to establish whether clinical
outcomes might be improved by lesion selection for PCI using the quantitative flow
ratio (QFR), a novel angiography-based approach to estimate the fractional flow reserve.
</p>